MVA-based SARS-CoV-2 Vaccine MVA-SARS-2-S

Preferred Label : MVA-based SARS-CoV-2 Vaccine MVA-SARS-2-S;

NCIt synonyms : MVA-based Covid-19 Vaccine MVA-SARS-2-S;

NCIt definition : A vaccine comprised of a recombinant modified Vaccinia virus Ankara (MVA) viral vector expressing full-length severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) surface antigen spike (S) protein, with potential immunizing activity against SARS-CoV-2. Upon administration of the MVA-based SARS-CoV-2 Vaccine MVA-SARS-2-S, the SARS-CoV-2 S protein is presented to the immune system. This may activate both humoral and cellular immune responses which may result in protection against SARS-CoV-2 infection.;

Molecule name : MVA-SARS-2-S;

NCI Metathesaurus CUI : CL1770957;

Details

Origin ID

C182628;

UMLS CUI

C5439908;

Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Immunologic Factor [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
concept_is_in_subset
- NCIt COVID-19 Agent Terminology [NCIt concept]
- NCIt COVID-19 Terminology [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients